Cymbalta (duloxetine) and Prozac (fluoxetine) come from different antidepressant classes and clear the body at very different speeds, which affects everything from pain treatment options to how each drug interacts with other medicines. Cymbalta is an SNRI with several pain-related FDA approvals; Prozac is a pure SSRI with one of the longest half-lives of any antidepressant. This guide compares mechanism, approved uses, half-life and its practical consequences, side effects, and the specific liver and alcohol warning unique to Cymbalta.
This is general information, not medical advice.
Cymbalta vs Prozac at a glance
| Cymbalta (duloxetine) | Prozac (fluoxetine) | |
|---|---|---|
| Drug class | SNRI | SSRI |
| FDA-approved for | MDD, GAD, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain | MDD, OCD, bulimia nervosa, panic disorder |
| Half-life | About 12 hours | 4-6 days (fluoxetine) plus 4-16 days for active metabolite norfluoxetine |
| Pain indications | Yes, several | None |
| Key warning | Not for patients with substantial alcohol use or chronic liver disease | Long CYP2D6 inhibition persisting weeks after stopping; 5-week MAOI washout |
| Discontinuation | Can occur; moderate | Uncommon due to long half-life |
What each is approved for
Cymbalta covers major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain.
Prozac covers major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder (plus premenstrual dysphoric disorder under the Sarafem brand, and bipolar depression or treatment-resistant depression only in combination with olanzapine).
Neither drug’s list fully overlaps with the other. If pain is a factor, Cymbalta has an approved role Prozac lacks. If bulimia or OCD is the diagnosis, Prozac has approvals Cymbalta lacks.
How they work
Prozac selectively blocks serotonin reuptake. Cymbalta blocks reuptake of both serotonin and norepinephrine, the dual mechanism behind its pain-related approvals, since norepinephrine pathways contribute to the body’s pain-modulating systems in the spinal cord and brain, separate from mood effects.
Half-life: the biggest practical difference
This is where the two drugs diverge most sharply. Cymbalta’s half-life is roughly 12 hours, requiring consistent daily dosing to maintain steady blood levels. Prozac’s half-life is 4 to 6 days, and its active metabolite norfluoxetine persists for 4 to 16 days, meaning the drug and its active byproduct remain in the body for weeks after the last dose.
The practical consequences:
- Missed doses. A missed Cymbalta dose has more immediate impact on blood levels than a missed Prozac dose.
- Discontinuation. Prozac’s slow clearance acts as a natural taper, making discontinuation syndrome less common; Cymbalta’s faster clearance means abrupt stopping is more likely to produce noticeable symptoms (dizziness, nausea, irritability), so a gradual dose reduction is recommended.
- MAOI switching. After stopping Prozac, the label requires waiting at least 5 weeks before starting an MAOI, far longer than the standard 14-day wait after stopping Cymbalta.
- Drug interaction persistence. Fluoxetine’s strong CYP2D6 inhibition persists for weeks after the last dose because the drug itself persists that long; Cymbalta’s more moderate CYP2D6 inhibition clears within days of stopping.
Side effects
Both cause nausea, sexual side effects, and sleep changes. Cymbalta more specifically causes increased sweating and can raise blood pressure, both linked to its norepinephrine activity; Prozac’s label documents modest weight loss in bulimia trials, and Prozac is generally considered less likely than Cymbalta to affect blood pressure, being a pure SSRI.
Cymbalta’s liver and alcohol warning
Cymbalta carries a specific label warning that it should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease, following a 2005 FDA and Eli Lilly safety alert about hepatotoxicity, including cases in patients who consumed large quantities of alcohol during clinical trials. See our guide to Cymbalta and alcohol for full detail. Prozac carries no comparable liver-specific warning, though its label notes that fluoxetine’s elimination half-life is prolonged in patients with cirrhosis (a mean of 7.6 days versus 2 to 3 days in those without liver disease), so dosing may still need adjustment in liver impairment even without the same explicit alcohol-use warning Cymbalta carries.
Drug interactions
Both are contraindicated with MAOIs; Prozac requires the notably longer 5-week washout after stopping, versus the standard 14 days for Cymbalta. Both raise serotonin syndrome risk with other serotonergic drugs and bleeding risk with NSAIDs, aspirin, or anticoagulants. Fluoxetine’s CYP2D6 inhibition is stronger and longer-lasting than duloxetine’s, which matters for anyone taking other CYP2D6-metabolized drugs, including tamoxifen and certain heart medicines.
Dosing
Cymbalta typically starts at 30 to 60 mg once daily for depression and anxiety, with a similar or lower starting point for pain conditions, and a maximum generally around 60 mg/day for most patients under standard use.
Prozac starts at 20 mg once daily in the morning for MDD and OCD, with studies showing 20 mg/day is sufficient for a satisfactory response in most cases of MDD; bulimia nervosa uses a notably higher starting dose of 60 mg/day; panic disorder starts lower, at 10 mg/day, increasing to 20 mg after a week. A once-weekly 90 mg delayed-release capsule (Prozac Weekly) exists for maintenance therapy, made possible by fluoxetine’s long half-life.
Practical tips
- If you take Cymbalta, take it consistently at the same time each day given its shorter half-life, do not stop it abruptly, and be upfront with your prescriber about any regular alcohol use.
- If you take Prozac, take it in the morning since it can be activating, and remember that its long half-life means both benefits and interactions can persist for weeks after your last dose, information worth sharing with any new prescriber or pharmacist even well after stopping.
- If pain is part of your picture alongside depression or anxiety, raise this specifically with your prescriber, since it may tip the choice toward Cymbalta given its additional approved pain indications.
- Never combine either drug with an MAOI without observing the specific washout period required (14 days minimum for Cymbalta after stopping an MAOI before starting; at least 5 weeks after stopping Prozac before starting an MAOI).
What research comparisons show
Large network meta-analyses pooling many antidepressant trials, such as the 2018 Cipriani analysis in The Lancet covering 21 antidepressants, generally find that most approved antidepressants, including both duloxetine and fluoxetine, outperform placebo, with the differences between individual drugs smaller than the gap between any of them and placebo. Fluoxetine has sometimes ranked in a middle position on combined efficacy-and-tolerability measures in such analyses, while duloxetine’s ranking varies depending on the specific analysis and outcome measured. Neither drug has a clearly established efficacy edge over the other for depression itself; the decision more often comes down to the specific factors above: pain indications, half-life and interaction timing, and the liver and alcohol consideration unique to Cymbalta.
Who each might suit
Factors that may point toward Cymbalta:
- Depression or anxiety with coexisting diabetic neuropathy, fibromyalgia, or chronic pain
- A need for a shorter drug-interaction window when adding or changing other medicines
- No substantial alcohol use or liver disease
Factors that may point toward Prozac:
- Bulimia nervosa or OCD as the diagnosis
- A history of difficulty with missed doses or medication adherence, given Prozac’s forgiving half-life
- Depression associated with bipolar I disorder or treatment resistance, where the fluoxetine-olanzapine combination (Symbyax) has a specific approval
Frequently asked questions
Can Prozac treat nerve pain like Cymbalta?
No. Prozac has no FDA-approved pain indication. Cymbalta is specifically approved for diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain.
Which stays in your system longer, Cymbalta or Prozac?
Prozac, by a wide margin. Its half-life is 4 to 6 days plus 4 to 16 days for its active metabolite, compared with Cymbalta’s roughly 12-hour half-life.
Is Cymbalta safe with alcohol?
The label specifically advises against prescribing it to patients with substantial alcohol use, due to a possible liver-injury interaction. See our detailed guide on Cymbalta and alcohol.
Why does switching from Prozac to an MAOI take so much longer than from Cymbalta?
Because fluoxetine and its active metabolite clear the body so slowly, the FDA label requires at least a 5-week wait before starting an MAOI after stopping Prozac, versus the standard 14-day wait for Cymbalta.
Does Cymbalta cause more sweating than Prozac?
Increased sweating is more frequently reported with Cymbalta, likely related to its added norepinephrine activity, a mechanism Prozac does not share.